Literature DB >> 8409392

Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo.

J R Newcomb1, P Cresswell.   

Abstract

The MHC class II alpha beta heterodimer associates with invariant (I) chain in the endoplasmic reticulum and remains associated until the complex reaches a post-Golgi compartment. During early stages of transport, I chain blocks peptide binding to alpha beta dimers. I chain is proteolytically cleaved in a post-Golgi compartment releasing alpha beta dimers that can bind antigenic peptides and transport them to the cell surface. Human B lymphoblastoid cell lines grown in leupeptin, a sulfhydryl protease inhibitor, accumulate a partial proteolytic product of the I chain called leupeptin-induced protein (LIP). LIP remains associated with alpha beta dimers. We find, using chemical cross-linking, sucrose gradient sedimentation, and size exclusion chromatography, that the alpha beta LIP complex retains the nine-subunit structure described for alpha beta I complexes. Unlike the alpha beta I complex, in certain detergents the alpha beta LIP nonamer is unstable and dissociates into trimers containing one alpha, beta, and LIP molecule. This finding emphasizes the reported stoichiometry of the alpha beta I complex as a nine-subunit structure comprised of three alpha beta I trimers. Also, these data indicate that the region(s) of I chain necessary for retaining the nonameric structure lie within the LIP fragment, but that domains to the C-terminus of the LIP cleavage site act to further stabilize the nine chain structure. In addition, alpha beta I complexes containing forms of human I chain encoding the p35/p43 N-terminal cytoplasmic extension responsible for endoplasmic reticulum retention can transport to post-Golgi proteolytic compartments where LIP is formed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409392

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.

Authors:  K Frauwirth; N Shastri
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.

Authors:  Crystal C Walline; Sarah N Deffit; Nan Wang; Lynette M Guindon; Victoria L Crotzer; Jianyun Liu; Kristin Hollister; Laurence C Eisenlohr; Randy R Brutkiewicz; Mark H Kaplan; Janice S Blum
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

3.  Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.

Authors:  T Kuwana; P A Peterson; L Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

4.  I-Ag7 is subject to post-translational chaperoning by CLIP.

Authors:  Cornelia H Rinderknecht; Ning Lu; Oliver Crespo; Phi Truong; Tieying Hou; Nan Wang; Narendiran Rajasekaran; Elizabeth D Mellins
Journal:  Int Immunol       Date:  2010-06-13       Impact factor: 4.823

5.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

6.  Cathepsin S activity regulates antigen presentation and immunity.

Authors:  R J Riese; R N Mitchell; J A Villadangos; G P Shi; J T Palmer; E R Karp; G T De Sanctis; H L Ploegh; H A Chapman
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles.

Authors:  S Amigorena; P Webster; J Drake; J Newcomb; P Cresswell; I Mellman
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

8.  Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.

Authors:  P A Warmerdam; E O Long; P A Roche
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

9.  An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum.

Authors:  M P Schutze; P A Peterson; M R Jackson
Journal:  EMBO J       Date:  1994-04-01       Impact factor: 11.598

10.  T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.

Authors:  S Morkowski; A W Goldrath; S Eastman; L Ramachandra; D C Freed; P Whiteley
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.